Citi Pharma (KAR:CPHL) Tax Rate %: 0.00% (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KAR:CPHL Citi Pharma Ltd KAR:CPHL
15 GF Score
Price ₨75.16
! 1 Warning Sign
View Full Analysis

What is Citi Pharma Tax Rate %?

Citi Pharma KAR:CPHL -0.52% 15 Tax Rate % is 0.00% as of . 20. GuruFocus rates KAR:CPHL with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Citi Pharma's Tax Expense for the six months ended in . 20 was ₨0.00 Mil. Citi Pharma's Pre-Tax Income for the six months ended in . 20 was ₨0.00 Mil. Therefore, Citi Pharma's Tax Rate % for the quarter that ended in . 20 was 0.00%.

Citi Pharma Tax Rate % Related Terms

Citi Pharma Tax Rate % Historical Data

* Premium members only.

The historical data trend for Citi Pharma's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Citi Pharma Tax Rate % Chart

Citi Pharma Annual Data
Trend
Tax Rate %

Citi Pharma Semi-Annual Data
Tax Rate %
KAR:CPHL
15GF Score
Citi Pharma Ltd KAR:CPHL
Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Citi Pharma Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Citi Pharma's Tax Rate % for the fiscal year that ended in . 20 is calculated as

Tax Rate %=Tax Expense (A: . 20 )/Pre-Tax Income (A: . 20 )
=/
= %

Citi Pharma's Tax Rate % for the quarter that ended in . 20 is calculated as

Tax Rate %=Tax Expense (Q: . 20 )/Pre-Tax Income (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Rate % →
What does a Tax Rate % of 0.00% mean?
Citi Pharma (KAR:CPHL) has a Tax Rate % of 0.00% as of . 20.
Is Citi Pharma's Tax Rate % too high?
Citi Pharma's current Tax Rate % is 0.00%. Overall, Citi Pharma has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Citi Pharma's Tax Rate % compare to ZTS and UTHR?
Citi Pharma's Tax Rate % of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Rate % for a Drug Manufacturers company?
A good Tax Rate % depends on the Drug Manufacturers industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Rate % mean?
A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. Citi Pharma's current Tax Rate % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Citi Pharma stock overvalued right now?
Citi Pharma (KAR:CPHL) has a current Tax Rate % of 0.00%. The current Tax Rate % is 0.00%. Citi Pharma's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Rate % calculated?
Tax Rate % is calculated from a company's financial statements. For Citi Pharma (KAR:CPHL), the current Tax Rate % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Citi Pharma Business Description

Address 588 Q Block, M.A., Johar Town, Lahore, PB, PAK
Citi Pharma Ltd is engaged in the manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. Its product portfolio includes API segment, Formulation segment, Cephalosporin formulation, and Nutraceuticals. The API segment includes Paracetamol, Penicillin/Amoxicillin, Levofloxacin, Cefixime/Cephalosporin, Ciprofloxacin, Cephradine, Norfloxacin, Aspirin, and Ibuprofen.
15GF Score

Get the complete analysis for KAR:CPHL

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨75.16
Price